Purchase Order 75F40126P00163

The Food and Drug Administration awarded a purchase order to Emulate Inc. for five liver human emulation system 24-pack quad liver chip kits, valued at $104,500, on June 27, 2023, under a Total Small Business set-aside. Performance is to occur in Boston, Massachusetts, with an ultimate completion date of June 26, 2024. The procurement is for firm fixed-price commercial organ-on-chip microphysiological systems designed to support biomedical research and regulatory science applications,...

The Food and Drug Administration awarded a firm fixed-price purchase order to Emulate Inc. for $213,100 on August 14, 2023, to provide a human emulation system including an Orb-HM1 hub module (used), two ZOE-CM2 culture modules (used), one new ZOE-CM2 culture module with one-year warranty, and a service agreement covering the three used items. The order carried a total small business set-aside. Work is performed in Boston, Massachusetts, with an ultimate completion date of August 14, 2024. The...

The Food and Drug Administration awarded a Total Small Business set-aside purchase order to Emulate Inc. on June 28, 2022, for the procurement of organ-on-chip microphysiological systems. The contract specifies delivery of two (2) Human Emulation System Zoe Culture Module 2 units and two (2) Orb Hub Modules, with a firm fixed price ceiling value of $218.1K and an ultimate completion date of August 27, 2023. Performance will be conducted in Laurel, Maryland. Emulate Inc., headquartered in Boston,...

The U.S. Food and Drug Administration awarded a $200.3K purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems, for the procurement of a Human Emulation System. The contract, awarded on March 29, 2023, with an ultimate completion date of October 1, 2023, carries a Total Small Business set-aside designation and employs firm fixed-price pricing. The award supports FDA's regulatory science initiatives and efforts to advance...

The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...

The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...

The Food and Drug Administration (FDA) awarded a $48,680.00 firm fixed price purchase order to Emulate Inc., a for-profit small business, for the purchase of Emulate Chip-S1 Basic Research Kits. This contract supports the FDA's regulatory science initiatives and advances the agency's work on non-animal testing approaches. The award has an ultimate completion date of August 21, 2025. Emulate Inc. has previously received federal grants, including a cooperative agreement from the Defense Advanced...

The U.S. Food and Drug Administration (FDA) awarded a $120,950.00 firm fixed-price purchase order contract to Tissuse GMBH, a for-profit organization based in Germany. The contract is for the development of a multi-organ human-on-a-chip system, with a period of performance ending on December 31, 2024. The contract does not have a set-aside designation. Based on the FDA's role in evaluating medical technologies, this contract is likely related to the agency's efforts to advance the development of...

<p>The Food and Drug Administration issued a purchase order to Repligen Corporation on May 28, 2026, for XCell Lab Controllers and Accessories valued at $174,560.00. Work is performed in Waltham, Massachusetts, with a completion date of September 30, 2026. The order carries no small business set-aside.</p>

The Food and Drug Administration awarded a $19,266.67 firm fixed-price purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems. The contract, posted in February 2023 with an award date of April 20, 2023, provides a full-service preventative maintenance agreement for two Zoe Culture Modules and two Orb Hub Modules through a base year plus four option years. The contract utilizes no set-aside designation and specifies...